Inactief instrument

Andere talen Curative Biotechnology, Inc. Other OTC

Aandelen

CTYX

US20786Q2093

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Curative Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	06/05
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors	22/03
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors	08/01
Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $7.999998 million.	25/11
Curative Biotechnology, Inc. Announces Nomination of Dr. Jeffrey Liebmann to Board of Directors	31-10-23
Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $7.999998 million.	07-09-23
Curative Biotechnology, Inc. Announces Establishment of Japanese Subsidiary for Licensing Transactions and Asset Acquisitions	07-06-23
Curative Biotechnology Announces Establishment of Japanese Subsidiary for Licensing Transactions and Asset Acquisitions	06-06-23
Curative Biotechnology, Inc. Files Patent on Ophthalmic Formulation	24-05-23
Curative Biotechnology, Inc. Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study	05-01-23
Curative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study	05-01-23
Curative Biotechnology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	16-11-22
Curative Biotechnology, Inc. has filed an IPO in the amount of $7.999998 million.	07-11-22
Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $8 million.	31-10-22
Curative Biotechnology Announces Intent to Uplist to NYSE American Exchange	27-09-22
Curative Biotechnology Announces Intent to Uplist to NYSE American Exchange	27-09-22
Curative Biotechnology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	01-09-22
Curative Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	29-06-22
Curative Biotechnology Inc. Adds Biotech Veteran Lawrence S. Zaslow to Board of Directors	16-06-22
Curative Biotechnology Inc. Adds Biotech Veteran Lawrence S. Zaslow to Board of Directors	16-06-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Curative Biotechnology, Inc. Other OTC

Aandelen

CTYX

US20786Q2093

Andere talen

Filters